UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is related to risk factors of coronary artery disease, such as dyslipidemia, diabetes, and metabolic syndrome, which are closely linked with visceral adiposity. The aim of this study was to investigate whether NAFLD was associated with coronary artery calcification (CAC), which is used as a surrogate marker for coronary atherosclerosis independent of computed tomography (CT)-measured visceral adiposity. Out of 5,648 subjects who visited one of our health screening centers between 2003 and 2008, we enrolled 4,023 subjects (mean age, 56.9 ± 9.4 years; 60.7% males) without known liver disease or a history of ischemic heart disease. CAC score was evaluated using the Agatston method. On univariate analysis, the presence of CAC (score >0) was significantly associated with age, sex, body mass index, aspartate aminotransferase, alanine aminotransferase, high-density lipoprotein cholesterol, triglycerides, and increased risk of diabetes, hypertension, smoking, and NAFLD. Increasing CAC scores (0, <10, 10-100, ≥ 100) were associated with higher prevalence of NAFLD (odds ratio [OR], 1.84; 95% confidence interval [CI], 1.61-2.10; P<0.001). Multivariable ordinal regression analysis was adjusted for traditional risk factors, and CT-measured visceral adipose tissue area in a subgroup of subjects showed that the increased CAC scores were significantly associated with the presence of NAFLD (OR, 1.28, 95% CI, 1.04-1.59; P = 0.023) independent of visceral adiposity. CONCLUSION: Patients with NAFLD are at increased risk for coronary atherosclerosis independent of classical coronary risk factors, including visceral adiposity. These data suggest that NAFLD might be an independent risk factor for coronary artery disease.
UNLABELLED: Nonalcoholic fatty liver disease (NAFLD) is related to risk factors of coronary artery disease, such as dyslipidemia, diabetes, and metabolic syndrome, which are closely linked with visceral adiposity. The aim of this study was to investigate whether NAFLD was associated with coronary artery calcification (CAC), which is used as a surrogate marker for coronary atherosclerosis independent of computed tomography (CT)-measured visceral adiposity. Out of 5,648 subjects who visited one of our health screening centers between 2003 and 2008, we enrolled 4,023 subjects (mean age, 56.9 ± 9.4 years; 60.7% males) without known liver disease or a history of ischemic heart disease. CAC score was evaluated using the Agatston method. On univariate analysis, the presence of CAC (score >0) was significantly associated with age, sex, body mass index, aspartate aminotransferase, alanine aminotransferase, high-density lipoprotein cholesterol, triglycerides, and increased risk of diabetes, hypertension, smoking, and NAFLD. Increasing CAC scores (0, <10, 10-100, ≥ 100) were associated with higher prevalence of NAFLD (odds ratio [OR], 1.84; 95% confidence interval [CI], 1.61-2.10; P<0.001). Multivariable ordinal regression analysis was adjusted for traditional risk factors, and CT-measured visceral adipose tissue area in a subgroup of subjects showed that the increased CAC scores were significantly associated with the presence of NAFLD (OR, 1.28, 95% CI, 1.04-1.59; P = 0.023) independent of visceral adiposity. CONCLUSION:Patients with NAFLD are at increased risk for coronary atherosclerosis independent of classical coronary risk factors, including visceral adiposity. These data suggest that NAFLD might be an independent risk factor for coronary artery disease.
Authors: Leon A Adams; James F Lymp; Jenny St Sauver; Schuyler O Sanderson; Keith D Lindor; Ariel Feldstein; Paul Angulo Journal: Gastroenterology Date: 2005-07 Impact factor: 22.682
Authors: Allen J Taylor; Jody Bindeman; Irwin Feuerstein; Felix Cao; Michael Brazaitis; Patrick G O'Malley Journal: J Am Coll Cardiol Date: 2005-09-06 Impact factor: 24.094
Authors: Angel Brea; Daniel Mosquera; Eva Martín; Ana Arizti; José L Cordero; Emilio Ros Journal: Arterioscler Thromb Vasc Biol Date: 2005-02-24 Impact factor: 8.311
Authors: Jeffrey D Browning; Lidia S Szczepaniak; Robert Dobbins; Pamela Nuremberg; Jay D Horton; Jonathan C Cohen; Scott M Grundy; Helen H Hobbs Journal: Hepatology Date: 2004-12 Impact factor: 17.425
Authors: James G Terry; J Jeffrey Carr; Rong Tang; Gregory W Evans; Ethel O Kouba; Rong Shi; Delilah R Cook; Jose L C Vieira; Mark A Espeland; Michele F Mercuri; John R Crouse Journal: Arterioscler Thromb Vasc Biol Date: 2005-06-09 Impact factor: 8.311
Authors: K M Rexrode; V J Carey; C H Hennekens; E E Walters; G A Colditz; M J Stampfer; W C Willett; J E Manson Journal: JAMA Date: 1998-12-02 Impact factor: 56.272
Authors: Stefan B Puchner; Michael T Lu; Thomas Mayrhofer; Ting Liu; Amit Pursnani; Brian B Ghoshhajra; Quynh A Truong; Stephen D Wiviott; Jerome L Fleg; Udo Hoffmann; Maros Ferencik Journal: Radiology Date: 2014-11-04 Impact factor: 11.105
Authors: Lisa B VanWagner; Hongyan Ning; Cora E Lewis; Christina M Shay; John Wilkins; J Jeffrey Carr; James G Terry; Donald M Lloyd-Jones; David R Jacobs; Mercedes R Carnethon Journal: Atherosclerosis Date: 2014-06-10 Impact factor: 5.162
Authors: Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder Journal: J Magn Reson Imaging Date: 2013-10-10 Impact factor: 4.813
Authors: Alejandro A Diaz; Tom P Young; Sila Kurugol; Erick Eckbo; Nina Muralidhar; Joshua K Chapman; Gregory L Kinney; James C Ross; Raul San Jose Estepar; Rola Harmouche; Jennifer L Black-Shinn; Matthew Budoff; Russell P Bowler; John Hokanson; George R Washko Journal: Chronic Obstr Pulm Dis Date: 2015
Authors: Jiankang Liu; Solomon K Musani; Aurelian Bidulescu; J Jeffery Carr; James G Wilson; Herman A Taylor; Caroline S Fox Journal: Atherosclerosis Date: 2012-08-10 Impact factor: 5.162